UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.12B |
| 2 |
Apple
AAPL
|
+$1.08B |
| 3 |
Microsoft
MSFT
|
+$1.05B |
| 4 |
Nike
NKE
|
+$1.03B |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$821M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BioMarin Pharmaceuticals
BMRN
|
+$389M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$383M |
| 3 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$348M |
| 4 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$263M |
| 5 |
NRG Energy
NRG
|
+$237M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.8% |
| 2 | Financials | 8.25% |
| 3 | Healthcare | 6.4% |
| 4 | Consumer Discretionary | 5.85% |
| 5 | Communication Services | 4.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HPF
2876
John Hancock Preferred Income Fund II
HPF
$345M
| $5M | ﹤0.01% |
294,846
+9,579
| +3% | +$161K |
|
2877
Sociedad Química y Minera de Chile
SQM
$20.6B
| $4.99M | ﹤0.01% |
122,404
+26,735
| +28% | +$1.24M |
|
2878
Invesco Senior Income Trust
VVR
$454M
| $4.97M | ﹤0.01% |
1,153,230
-23,491
| -2% | -$101K |
|
2879
Archer Aviation
ACHR
$4.26B
| $4.97M | ﹤0.01% |
1,411,176
+482,134
| +52% | +$1.79M |
|
2880
Spire
SR
$4.85B
| $4.96M | ﹤0.01% |
81,688
-12,127
| -13% | -$733K |
|
|
HTLF
2881
DELISTED
Heartland Financial USA, Inc.
HTLF
| $4.96M | ﹤0.01% |
111,516
+41,381
| +59% | +$1.68M |
|
|
NBH
2882
Neuberger Municipal Fund Inc
NBH
$304M
| $4.95M | ﹤0.01% |
463,509
+4,425
| +1% | +$45.5K |
|
2883
American Century US Quality Growth ETF
QGRO
$2.02B
| $4.95M | ﹤0.01% |
57,529
-11,854
| -17% | -$987K |
|
2884
Pacer Industrial Real Estate ETF
INDS
$117M
| $4.94M | ﹤0.01% |
130,709
-10,340
| -7% | -$386K |
|
|
NIE
2885
Virtus Equity & Convertible Income Fund
NIE
$732M
| $4.94M | ﹤0.01% |
212,657
+714
| +0.3% | +$16K |
|
|
ETW
2886
Eaton Vance Tax-Managed Global Buy-Write Opportunities Fund
ETW
$1.06B
| $4.94M | ﹤0.01% |
597,316
+25,697
| +4% | +$208K |
|
|
COOP
2887
DELISTED
Mr. Cooper
COOP
| $4.94M | ﹤0.01% |
60,777
-4,724
| -7% | -$380K |
|
2888
NexGen Energy
NXE
$6.99B
| $4.93M | ﹤0.01% |
706,895
+181,030
| +34% | +$1.39M |
|
2889
Nuveen New York Municipal Value Fund
NNY
$157M
| $4.93M | ﹤0.01% |
594,927
-10,554
| -2% | -$86.7K |
|
2890
Invesco Biotechnology & Genome ETF
PBE
$292M
| $4.92M | ﹤0.01% |
75,944
-11,117
| -13% | -$704K |
|
2891
Calumet Specialty Products
CLMT
$3.44B
| $4.92M | ﹤0.01% |
306,402
+158,517
| +107% | +$2.5M |
|
2892
Amphastar Pharmaceuticals
AMPH
$916M
| $4.91M | ﹤0.01% |
122,681
+42,229
| +52% | +$1.75M |
|
2893
CALL
CME Group
CME
$94.8B
| $4.9M | ﹤0.01% |
24,900
-101,600
| -80% | -$21M |
|
2894
Ashland
ASH
$3.5B
| $4.89M | ﹤0.01% |
51,801
-3,188
| -6% | -$310K |
|
2895
Davis Select Worldwide ETF
DWLD
$613M
| $4.89M | ﹤0.01% |
146,584
-3,164
| -2% | -$106K |
|
|
BWIN
2896
Baldwin Insurance Group
BWIN
$2.86B
| $4.89M | ﹤0.01% |
137,761
+5,692
| +4% | +$176K |
|
2897
BlackRock Corporate High Yield Fund
HYT
$1.37B
| $4.88M | ﹤0.01% |
504,078
-43,930
| -8% | -$426K |
|
2898
Transmedics
TMDX
$2.91B
| $4.88M | ﹤0.01% |
32,411
-12,788
| -28% | -$1.53M |
|
|
DEA
2899
Easterly Government Properties
DEA
$1.18B
| $4.86M | ﹤0.01% |
157,196
-6,449
| -4% | -$191K |
|
2900
CALL
Yum China
YUMC
$16.3B
| $4.85M | ﹤0.01% |
157,250
+69,950
| +80% | +$2.56M |
|
Similar funds
UBS Group's Q2 2024 Portfolio in Review
As of Q2 2024, UBS Group held 10,501 positions worth $405B, up 0.81% from $402B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
UBS Group's Q2 2024 filing shows 1,231 new, 3,688 increased, 4,131 reduced and 1,043 closed positions. Its largest new stake was SLB Ltd: 10,925,731 shares worth $515M. The largest sale was BioMarin Pharmaceuticals, an estimated $389M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.
- UBS Group's largest Q2 2024 buy was SLB Ltd: 10,925,731 shares worth $515M.
- UBS Group added most to NVIDIA in Q2 2024, an estimated $1.12B increase.
- UBS Group's biggest Q2 2024 reduction was BioMarin Pharmaceuticals, cutting an estimated $389M.
- UBS Group fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $263M.
- UBS Group's ten largest holdings make up 18% of its $405B portfolio in Q2 2024.
- UBS Group opened 1,231 new positions and closed 1,043 in Q2 2024.
- UBS Group's portfolio value rose 0.81% quarter-over-quarter to $405B.
Based on UBS Group's 13F filing for Q2 2024, filed 14 Aug 2024.